Recombinant Human MALT1 protein, His/Thioredoxin-tagged
Cat.No. : | MALT1-857H |
Product Overview : | Recombinant Human MALT1((Gln 2-Ile57) fused with His/Thioredoxin tag at N-terminal was expressed in E. coli. |
- Specification
- Gene Information
- Related Products
- Download
Description : | This gene has been found to be recurrently rearranged in chromosomal translocation with two other genes - baculoviral IAP repeat-containing protein 3 (also known as apoptosis inhibitor 2) and immunoglobulin heavy chain locus - in mucosa-associated lymphoid tissue lymphomas. The protein encoded by this gene may play a role in NF-kappaB activation. Two alternatively spliced transcript variants encoding different isoforms have been described for this gene. |
Source : | E. coli |
Species : | Human |
Tag : | His&Trx |
Form : | Supplied as a 0.45 µm filtered solution in 50 mM NaH2PO4 (pH 7.4), 0.3 M NaCl, 80 mM imidazole, 6 M urea. |
Molecular Mass : | 27 kDa (including N-terminal thioredoxin tag) |
Purity : | ~0.9 |
Applications : | ELISA, EIA, protein-protein interaction studies, Western Blotting, Dot Blotting, Immunoprecipitation, Protein Array |
Storage : | Upon arrival, the protein may be stored for 2 weeks at 4 centigrade. For long term storage, it is recommended to store at -20 centigrade or -80 centigrade in appropriate aliquots. Avoid repeated freeze-thaw cycles. |
Protein length : | Gln2-Ile57 |
Gene Name : | MALT1 mucosa associated lymphoid tissue lymphoma translocation gene 1 [ Homo sapiens ] |
Official Symbol : | MALT1 |
Synonyms : | MALT1; mucosa associated lymphoid tissue lymphoma translocation gene 1; MLT; mucosa-associated lymphoid tissue lymphoma translocation protein 1; paracaspase; caspase-like protein; MALT associated translocation; MALT lymphoma-associated translocation; MALT-lymphoma associated translocation; MLT1; DKFZp434L132; |
Gene ID : | 10892 |
mRNA Refseq : | NM_006785 |
Protein Refseq : | NP_006776 |
MIM : | 604860 |
UniProt ID : | Q9UDY8 |
Chromosome Location : | 18q21 |
Pathway : | Activation of NF-kappaB in B Cells, organism-specific biosystem; Adaptive Immune System, organism-specific biosystem; B cell receptor signaling pathway, organism-specific biosystem; B cell receptor signaling pathway, conserved biosystem; BCR signaling pathway, organism-specific biosystem; Canonical NF-kappaB pathway, organism-specific biosystem; Downstream Signaling Events Of B Cell Receptor (BCR), organism-specific biosystem; |
Function : | cysteine-type endopeptidase activity; contributes_to kinase activator activity; peptidase activity; protein binding; protein self-association; signal transducer activity; ubiquitin-protein ligase activity; |
Products Types
◆ Recombinant Protein | ||
Malt1-26HCL | Recombinant Mouse Malt1 overexpression lysate | +Inquiry |
MALT1-718H | Recombinant Human MALT1 protein, His-tagged | +Inquiry |
Malt1-3911M | Recombinant Mouse Malt1 Protein, Myc/DDK-tagged | +Inquiry |
MALT1-234H | Recombinant Human MALT1 Protein, MYC/DDK-tagged, C13 and N15-labeled | +Inquiry |
Malt1-14HCL | Recombinant Mouse Malt1 overexpression lysate | +Inquiry |
◆ Lysates | ||
MALT1-4527HCL | Recombinant Human MALT1 293 Cell Lysate | +Inquiry |
Related Gene
Not For Human Consumption!
Inquiry
- Reviews
- Q&As
Customer Reviews (3)
Write a reviewFrom recombinant protein production to modification or labeling services, the company is committed to assisting researchers in obtaining the MALT1 protein in the format and specifications required for their particular studies.
the manufacturer understands the importance of customization and can offer tailored solutions to meet specific research needs.
the MALT1 protein's exceptional qualities, combined with the manufacturer's comprehensive technical support, make it an ideal choice for researchers seeking reliable experimental materials and reliable assistance in their scientific endeavors.
Q&As (5)
Ask a questionMALT1 inhibitors are being investigated to prevent graft rejection and reduce the need for immunosuppressive drugs in transplant recipients.
Some genetic variations in MALT1 may influence susceptibility to certain diseases, including autoimmune conditions.
Yes, MALT1 is implicated in lymphoma and other hematological malignancies, making it a potential therapeutic target.
Yes, researchers are exploring MALT1 inhibitors as potential cancer therapeutics to block its activity in lymphomas.
MALT1 is involved in the activation of T and B cells, which are essential for the adaptive immune response.
Ask a Question for All MALT1 Products
Required fields are marked with *
My Review for All MALT1 Products
Required fields are marked with *
Inquiry Basket